Carregant...
Factor VIIa administration in traumatic brain injury: an AAST-MITC propensity score analysis
BACKGROUND: Recombinant factor VIIa (rFVIIa) has been used off-label as an adjunct in the reversal of warfarin therapy and management of hemorrhage after trauma. Only a handful of these reports are rigorous studies, from which results regarding safety and effectiveness have been mixed. There remains...
Guardat en:
| Publicat a: | Trauma Surg Acute Care Open |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5887758/ https://ncbi.nlm.nih.gov/pubmed/29766126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/tsaco-2017-000134 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|